These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 22426469

  • 1. Amino acid derivatives of the (-) enantiomer of gossypol are effective fusion inhibitors of human immunodeficiency virus type 1.
    An T, Ouyang W, Pan W, Guo D, Li J, Li L, Chen G, Yang J, Wu S, Tien P.
    Antiviral Res; 2012 Jun; 94(3):276-87. PubMed ID: 22426469
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Synthesis and biological evaluation of water-soluble derivatives of chiral gossypol as HIV fusion inhibitors targeting gp41.
    Yang J, Li LL, Li JR, Yang JX, Zhang F, Chen G, Yu R, Ouyang WJ, Wu SW.
    Bioorg Med Chem Lett; 2018 Jan 01; 28(1):49-52. PubMed ID: 29162455
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Protein design of a bacterially expressed HIV-1 gp41 fusion inhibitor.
    Deng Y, Zheng Q, Ketas TJ, Moore JP, Lu M.
    Biochemistry; 2007 Apr 10; 46(14):4360-9. PubMed ID: 17371053
    [Abstract] [Full Text] [Related]

  • 6. Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.
    Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.
    Cell; 2007 Apr 20; 129(2):263-75. PubMed ID: 17448989
    [Abstract] [Full Text] [Related]

  • 7. Interactions of HIV-1 inhibitory peptide T20 with the gp41 N-HR coiled coil.
    Champagne K, Shishido A, Root MJ.
    J Biol Chem; 2009 Feb 06; 284(6):3619-27. PubMed ID: 19073602
    [Abstract] [Full Text] [Related]

  • 8. Tannin inhibits HIV-1 entry by targeting gp41.
    Lü L, Liu SW, Jiang SB, Wu SG.
    Acta Pharmacol Sin; 2004 Feb 06; 25(2):213-8. PubMed ID: 14769212
    [Abstract] [Full Text] [Related]

  • 9. A novel enzyme-linked immunosorbent assay for screening HIV-1 fusion inhibitors targeting HIV-1 Gp41 core structure.
    Pang W, Wang RR, Gao YD, Yang LM, Sun Y, Huang JF, Tien P, Zheng YT.
    J Biomol Screen; 2011 Feb 06; 16(2):221-9. PubMed ID: 21297108
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Peptide P5 (residues 628-683), comprising the entire membrane proximal region of HIV-1 gp41 and its calcium-binding site, is a potent inhibitor of HIV-1 infection.
    Yu H, Tudor D, Alfsen A, Labrosse B, Clavel F, Bomsel M.
    Retrovirology; 2008 Oct 16; 5():93. PubMed ID: 18925934
    [Abstract] [Full Text] [Related]

  • 13. The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors.
    Gallo SA, Sackett K, Rawat SS, Shai Y, Blumenthal R.
    J Mol Biol; 2004 Jun 25; 340(1):9-14. PubMed ID: 15184018
    [Abstract] [Full Text] [Related]

  • 14. Conserved residues in the coiled-coil pocket of human immunodeficiency virus type 1 gp41 are essential for viral replication and interhelical interaction.
    Mo H, Konstantinidis AK, Stewart KD, Dekhtyar T, Ng T, Swift K, Matayoshi ED, Kati W, Kohlbrenner W, Molla A.
    Virology; 2004 Nov 24; 329(2):319-27. PubMed ID: 15518811
    [Abstract] [Full Text] [Related]

  • 15. Development of resistance to VIR-353 with cross-resistance to the natural HIV-1 entry virus inhibitory peptide (VIRIP).
    Gonzalez E, Ballana E, Clotet B, Esté JA.
    AIDS; 2011 Aug 24; 25(13):1557-83. PubMed ID: 21572303
    [Abstract] [Full Text] [Related]

  • 16. Covalent fusion inhibitors targeting HIV-1 gp41 deep pocket.
    Bai Y, Xue H, Wang K, Cai L, Qiu J, Bi S, Lai L, Cheng M, Liu S, Liu K.
    Amino Acids; 2013 Feb 24; 44(2):701-13. PubMed ID: 22961335
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis, and biological evaluation of highly potent small molecule-peptide conjugates as new HIV-1 fusion inhibitors.
    Wang C, Shi W, Cai L, Lu L, Wang Q, Zhang T, Li J, Zhang Z, Wang K, Xu L, Jiang X, Jiang S, Liu K.
    J Med Chem; 2013 Mar 28; 56(6):2527-39. PubMed ID: 23458727
    [Abstract] [Full Text] [Related]

  • 18. Human immunodeficiency virus (HIV) gp41 escape mutants: cross-resistance to peptide inhibitors of HIV fusion and altered receptor activation of gp120.
    Desmezieres E, Gupta N, Vassell R, He Y, Peden K, Sirota L, Yang Z, Wingfield P, Weiss CD.
    J Virol; 2005 Apr 28; 79(8):4774-81. PubMed ID: 15795263
    [Abstract] [Full Text] [Related]

  • 19. A multi-functional peptide as an HIV-1 entry inhibitor based on self-concentration, recognition, and covalent attachment.
    Zhao L, Tong P, Chen YX, Hu ZW, Wang K, Zhang YN, Zhao DS, Cai LF, Liu KL, Zhao YF, Li YM.
    Org Biomol Chem; 2012 Aug 28; 10(32):6512-20. PubMed ID: 22760295
    [Abstract] [Full Text] [Related]

  • 20. Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association.
    Maerz AL, Drummer HE, Wilson KA, Poumbourios P.
    J Virol; 2001 Jul 28; 75(14):6635-44. PubMed ID: 11413331
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.